CanadaPharmascience Inc. pms-IRBESARTAN 150 mg tablets (DIN 02317079), lot 667278, are affected; check the brand, strength and lot number on your product. The lot was recalled because it may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets. Verify whether your product is affected, consult your healthcare provider before stopping the product or if you have health concerns, contact Pharmascience Inc. with questions, and report side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Pharmascience Inc., 6111 avenue Royalmount, suite 100, Montréal, QC H4P 2T4.
How to identify it
Brand: Pharmascience Inc.; Product Name: pms-IRBESARTAN; Market Authorization: DIN 02317079; Dosage Form: Tablet; Strength: 150 mg; Lot Number: 667278
The hazard
The affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.
What to do
Verify whether your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)